| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2689 |
| Trial ID | NCT04888468 |
| Disease | Childhood Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | pCAR-19B |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents |
| Year | 2021 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PB01 |
| Cohort 1 | |||||||||
|
|||||||||